TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Eris Lifesciences Ltd ( (IN:ERIS) ).
Eris Lifesciences Ltd has announced a scheduled meeting with Mirae Asset Mutual Fund on March 24, 2025, as part of its ongoing engagement with institutional investors and analysts. The meeting, which will be conducted in-person, aims to discuss publicly available information without disclosing any unpublished price-sensitive information, reflecting the company’s commitment to transparency and regulatory compliance.
More about Eris Lifesciences Ltd
Eris Lifesciences Ltd operates in the pharmaceutical industry, focusing on the development and marketing of branded pharmaceutical products. The company primarily serves the Indian market, offering a range of therapeutic products across various medical specialties.
YTD Price Performance: -2.59%
Average Trading Volume: 5,171
Current Market Cap: 175.6B INR
Find detailed analytics on ERIS stock on TipRanks’ Stock Analysis page.